Carbohydrates

Quinn Karylle Fuentes · 28問 · 2年前

通報

問題一覧

Process where light energy occurs into chemical energy.

Photosynthesis.

Startch and glycogen is for energy reservoir.

Photosynthesis.

Plant products are source of carbohydrates and the average human diet contain 2/3 Carbs.

Photosynthesis.

Produce energy via glycosis.

Carbohydrates oxidation.

Provides short term energy reserve

Carbohydrates oxidation.

Glyosis means?

Release energy.

Supply atoms biochemically substance.

Carbohydrates.

Sugar and peptides Structurally framework of dna and rna.

Carbohydrates.

CHO + CHON

Glycogen.

Simple sugar 1 saccharides and cannot broken down/ hydrolyze into simpler carbohydrates.

Monosaccharides.

Classified depending on no. of carbon also have aldehyde and ketone.

Monosaccharides.

Mannose

Galactose

Glyceroses

Aldoses.

Dihydroxyacetone

Ketoses.

Erythrose

Aldoses.

Erythrolose

Ketoses.

Ribose.

Aldoses.

Ribulose.

Ketoses.

Glucose

Aldoses.

Fructoses

Ketoses.

Seduheptulose.

Ketoses.

2 sugar yield 2 molecules of monosaccharides.

Disaccharide.

Joined by glycosidic acid

Disaccharide.

Example of reducing in disaccharide

Maltose.

Glucose + Glucose

Maltose.

Example of non reducing in disaccharide

Sucrose.

Glucose + Fructose

Sucrose.

What are the common disaccharide

Lactose and Sucrose.

Glucose + Galactose

Lactose.

Yield 3 molecules of monosaccharides

Trisaccharides.

Glu + Glu + Glu

Maitotriose.

2-10 monosaccharides and a covalent bonded

Oligosaccharides.

Associated with structure and regulatory function in human body.

Oligosaccharide.

more than 10 monosaccharides covalent bonded.

Polysaccharides.

What are the examples of cellulose

Cotton, Paper and Wood.

What are the example of starch

Bread, pasta and rice.

not sweet & gen not soluble in water

Polysaccharide.

Pentosan

Araban & Xylan.

Hexosan

Glucosan.

Monosaccharides exist into two form (Left and right hand form)

Chirality.

What are the two objective of chirality

Achiral and Chiral.

All point meets, concid all point.

Achiral.

Does not meet all point

Chiral.

Both may be active.

Chirality.

Right handed EPI is 20x more active than left.

True.

Not super imposable on mirror image

Isomerism.

imgaes are optical isomers

Isomerism.

Contain chiral carbon is glyceraldehyde.

Isomerism.

Molecules chirality in 2D, repelresented as the intersection of vertical and horizontal line.

Fischers projection.

System used to designate the handedness.

D & L.

Are diastereoisomerism whose molecules differ only in the configuration at chiral center.

Epimer.

2D Structuresnotation that specifies the 3D structure of a cyclic form of a monosaccharide.

Haworth projection.

Cylic form bt rxn of C=O With Oh group on C5

Pyranose and furanose.

High structure monosaccharides are similar to the ring structure.

Pyranose and furanose.

Occurs about position 1.

Alpha and beta isomers.

Carbonyl and anomeric carbon.

Alpha and beta isomers.

Beta configuration means same direction (T/F)

True.

Alpha configuration means Opposite direction (T/F)

True.

Isomers differ of variation configuration or -OH & -H Carbon 2,3,4 glucose also know as epimer.

Epimers.

what is the most important epimers of glucose?

Mannose & Galactose.

Fructose has same molecular formula as glucose but differ in its stuctural form

Aldose and ketose.

Main metabolic of tissue

Glucose.

Physiologic sugar l; Grape sugar (20-30%) blood sugar.

Glucose.

Most abundant in nature (Aldohexose)

Glucose.

Isomerization glucose syrup for food manufacturing

Fructose.

Sweetest of all sugad, A good dietary sugar due to a higher sweetness.

Fructose.

Fruit sugar leulose ( Ketohexose)

Fructose.

Structure components of nucleic acid.

Ribose.

Brain sugar for brain and nerve tissue

Galactose.

Mammary gland for synthesis of lactose glycolipid and glycoprotein

Galactose.

Used to differentiate between blood type and 6 membered cyclic form

Galactose.

Linked with alcohol and aldehyde

Oxidation.

Yields from diff type or acidic sugar depending on the oxidation state.

Oxidation.

Weak oxidation agent

Tollens and Benedict.

Cell structure.

Cell structure.

28問 • 2年前

Quinn Karylle Fuentes · 29問 · 2年前

Electrolytes and non electrolytes

Electrolytes and non electrolytes

29問 • 2年前

Quinn Karylle Fuentes · 45問 · 2年前

45問 • 2年前

Quinn Karylle Fuentes · 38問 · 2年前

POST LAB (EXP 4)

POST LAB (EXP 4)

38問 • 2年前

Density and specific gravity

Density and specific gravity

Quinn Karylle Fuentes · 18問 · 2年前

FORCES OF ATTRACTION

FORCES OF ATTRACTION

18問 • 2年前

Quinn Karylle Fuentes · 63問 · 2年前

Microbial growth

Microbial growth

63問 • 2年前

Quinn Karylle Fuentes · 61問 · 2年前

Introduction.

Introduction.

61問 • 2年前

Quinn Karylle Fuentes · 97問 · 2年前

Microbial control.

Microbial control.

97問 • 2年前

Quinn Karylle Fuentes · 100問 · 2年前

States of matter

States of matter

100問 • 2年前

Quinn Karylle Fuentes · 86問 · 2年前

Introduction.

Introduction.

86問 • 2年前

Quinn Karylle Fuentes · 77問 · 2年前

Drug development.

Drug development.

77問 • 2年前

Quinn Karylle Fuentes · 9問 · 2年前

CGMP

CGMP

9問 • 2年前

Quinn Karylle Fuentes · 24問 · 2年前

Pharmaceutical ingredients.

Pharmaceutical ingredients.

24問 • 2年前

Quinn Karylle Fuentes · 43問 · 2年前

Powdered & granules

Powdered & granules

43問 • 2年前

Quinn Karylle Fuentes · 24問 · 2年前

Capsule.

Capsule.

24問 • 2年前

Quinn Karylle Fuentes · 23問 · 2年前

Tablets.

Tablets.

23問 • 2年前

Quinn Karylle Fuentes · 66問 · 2年前

Calculatiom of dose

Calculatiom of dose

66問 • 2年前

Quinn Karylle Fuentes · 29問 · 2年前

Postlab 5&6

Postlab 5&6

29問 • 2年前

Quinn Karylle Fuentes · 33問 · 2年前

COLLIGATIVE PROPERTIES.

COLLIGATIVE PROPERTIES.

33問 • 2年前

Quinn Karylle Fuentes · 69問 · 2年前

SEMI SOLID

SEMI SOLID

69問 • 2年前

Quinn Karylle Fuentes · 60問 · 2年前

Basic immunology

Basic immunology

60問 • 2年前

Quinn Karylle Fuentes · 62問 · 2年前

Basic immunology (2)

Basic immunology (2)

62問 • 2年前

Quinn Karylle Fuentes · 44問 · 2年前

Transdermal

Transdermal

44問 • 2年前

Quinn Karylle Fuentes · 43問 · 2年前

Distribution.

Distribution.

43問 • 2年前

Quinn Karylle Fuentes · 65問 · 2年前

Infectious disease.

Infectious disease.

65問 • 2年前

Quinn Karylle Fuentes · 79問 · 2年前

Infectious diseases (2)

Infectious diseases (2)

79問 • 2年前

Gram positive ( Bacteriology)

Gram positive ( Bacteriology)

All topic. ( Compressed.)

All topic. ( Compressed.)

Quinn Karylle Fuentes · 30問 · 2年前

All topic ( Compressed)

All topic ( Compressed)

30問 • 2年前

Quinn Karylle Fuentes · 13問 · 2年前

All topics (compressed)

All topics (compressed)

13問 • 2年前

Quinn Karylle Fuentes · 28問 · 2年前

Exercise 6 ; Isotonic solution.

Exercise 6 ; Isotonic solution.

28問 • 2年前

Quinn Karylle Fuentes · 16問 · 2年前

Exercise 5 : Buffers.

Exercise 5 : Buffers.

16問 • 2年前

Quinn Karylle Fuentes · 26問 · 2年前

Exercise 7 : Factors affecting solubility.

Exercise 7 : Factors affecting solubility.

26問 • 2年前

Quinn Karylle Fuentes · 23問 · 2年前

Experiment 8: Disintegration.

Experiment 8: Disintegration.

23問 • 2年前

Experiment 9 ; Interfacial phenomenon and surface tension.

Experiment 9 ; Interfacial phenomenon and surface tension.

EXP 9 : Aromatic ammonia spirit.

EXP 9 : Aromatic ammonia spirit.

EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

Quinn Karylle Fuentes · 20問 · 2年前

EXP 12: ACACIA MUCILAGE

EXP 12: ACACIA MUCILAGE

20問 • 2年前

Quinn Karylle Fuentes · 33問 · 2年前

EXP13&14 : Starch and Barrium sulfate.

EXP13&14 : Starch and Barrium sulfate.

33問 • 2年前

Quinn Karylle Fuentes · 37問 · 2年前

EXP 15 : Liquid petroleum emulsion 1.0

EXP 15 : Liquid petroleum emulsion 1.0

37問 • 2年前

Quinn Karylle Fuentes · 23問 · 2年前

EXP 15: Liquid petroleum emulsion 1.1

EXP 15: Liquid petroleum emulsion 1.1

23問 • 2年前

Enterobacteriaceae

Enterobacteriaceae

Quinn Karylle Fuentes · 28問 · 2年前

Enterobacteriaceae.

Enterobacteriaceae.

28問 • 2年前

Quinn Karylle Fuentes · 31問 · 2年前

LIQUID DOSAGE FORM 1.0

LIQUID DOSAGE FORM 1.0

31問 • 2年前

Quinn Karylle Fuentes · 12問 · 2年前

Liquid dosage form

Liquid dosage form

12問 • 2年前

Quinn Karylle Fuentes · 44問 · 2年前

MICROMERITICS 1.0

MICROMERITICS 1.0

44問 • 2年前

Quinn Karylle Fuentes · 22問 · 2年前

EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

22問 • 2年前

Quinn Karylle Fuentes · 40問 · 2年前

EXP 8 : KIRBY-BAUER TECHNIQUE

EXP 8 : KIRBY-BAUER TECHNIQUE

40問 • 2年前

Quinn Karylle Fuentes · 29問 · 2年前

EXP 9: STAPHYLOCOCCI

EXP 9: STAPHYLOCOCCI

29問 • 2年前

Quinn Karylle Fuentes · 41問 · 2年前

Drug incompatibilities.

Drug incompatibilities.

41問 • 2年前

Quinn Karylle Fuentes · 41問 · 2年前

Drug compatibilities.

Drug compatibilities.

41問 • 2年前

BACTERIOLOGY 3

BACTERIOLOGY 3

Quinn Karylle Fuentes · 30問 · 2年前

BACTERIOLOGY 3

BACTERIOLOGY 3

30問 • 2年前

Quinn Karylle Fuentes · 45問 · 2年前

SUSPENSION.

SUSPENSION.

45問 • 2年前

Quinn Karylle Fuentes · 40問 · 2年前

Colloidal.

Colloidal.

40問 • 2年前

Quinn Karylle Fuentes · 38問 · 2年前

BACTERIOLOGY 4 (Rickettsia)

BACTERIOLOGY 4 (Rickettsia)

38問 • 2年前

Quinn Karylle Fuentes · 44問 · 2年前

BACTERIOLOGY.

BACTERIOLOGY.

44問 • 2年前

Quinn Karylle Fuentes · 32問 · 2年前

Emulsion.

Emulsion.

32問 • 2年前

Quinn Karylle Fuentes · 42問 · 2年前

EMULSION

EMULSION

42問 • 2年前

Quinn Karylle Fuentes · 36問 · 2年前

MEDICAL RELATED PROBLEMS.

MEDICAL RELATED PROBLEMS.

36問 • 2年前

Quinn Karylle Fuentes · 33問 · 2年前

MEDICATION RELATED PROBLEMS.

MEDICATION RELATED PROBLEMS.

33問 • 2年前

Quinn Karylle Fuentes · 30問 · 2年前

Mycology.

Mycology.

30問 • 2年前

Mycology 2.0

Mycology 2.0

Quinn Karylle Fuentes · 15問 · 2年前

15問 • 2年前

Quinn Karylle Fuentes · 25問 · 2年前

ppr

ppr

25問 • 2年前

Quinn Karylle Fuentes · 20問 · 2年前

MEDICAL DEVICES.

MEDICAL DEVICES.

20問 • 2年前

Quinn Karylle Fuentes · 86問 · 1年前

Pharmacokinetics. (1.0)

Pharmacokinetics. (1.0)

86問 • 1年前

Quinn Karylle Fuentes · 100問 · 1年前

Pharmacokinetics (1.1)

Pharmacokinetics (1.1)

100問 • 1年前

Quinn Karylle Fuentes · 19問 · 1年前

Pharmacokinetics (1.2)

Pharmacokinetics (1.2)

19問 • 1年前

Quinn Karylle Fuentes · 17問 · 1年前

Introduction.

Introduction.

17問 • 1年前

Quinn Karylle Fuentes · 76問 · 1年前

Introduction of biochemistry

Introduction of biochemistry

76問 • 1年前

Quinn Karylle Fuentes · 56問 · 1年前

Intro medicanal chemistry.

Intro medicanal chemistry.

56問 • 1年前

Quinn Karylle Fuentes · 31問 · 1年前

Carbohydrates 1.1

Carbohydrates 1.1

31問 • 1年前

Quinn Karylle Fuentes · 56問 · 1年前

Detect and quality variation.

Detect and quality variation.

56問 • 1年前

Quinn Karylle Fuentes · 98問 · 1年前

INTRODUCTION

INTRODUCTION

98問 • 1年前

Quinn Karylle Fuentes · 15問 · 1年前

lab (1-2)

lab (1-2)

15問 • 1年前

Quinn Karylle Fuentes · 14問 · 1年前

lab 1-2

lab 1-2

14問 • 1年前

Quinn Karylle Fuentes · 45問 · 1年前

Pharmaceutical chemistry.

Pharmaceutical chemistry.

45問 • 1年前

Quinn Karylle Fuentes · 35問 · 1年前

Pharmaceutical chemistry 1.1

Pharmaceutical chemistry 1.1

35問 • 1年前

Quinn Karylle Fuentes · 39問 · 1年前

Unit 3.

Unit 3.

39問 • 1年前

Quinn Karylle Fuentes · 70問 · 1年前

Histamin and kinins

Histamin and kinins

70問 • 1年前

Quinn Karylle Fuentes · 45問 · 1年前

PUD.

PUD.

45問 • 1年前

Quinn Karylle Fuentes · 61問 · 1年前

61問 • 1年前

Quinn Karylle Fuentes · 67問 · 1年前

Lipids.

Lipids.

67問 • 1年前

Quinn Karylle Fuentes · 71問 · 1年前

lipids.

lipids.

71問 • 1年前

Quinn Karylle Fuentes · 93問 · 1年前

LAB ✨

LAB ✨

93問 • 1年前

Quinn Karylle Fuentes · 87問 · 1年前

Drug discovery.

Drug discovery.

87問 • 1年前

Quinn Karylle Fuentes · 13問 · 1年前

disease of lipids.

disease of lipids.

13問 • 1年前

Quinn Karylle Fuentes · 57問 · 1年前

Intro (identify structure)

Intro (identify structure)

57問 • 1年前

Quinn Karylle Fuentes · 98問 · 1年前

Carbohydrates

Carbohydrates

98問 • 1年前

Quinn Karylle Fuentes · 96問 · 1年前

Dynamic.

Dynamic.

96問 • 1年前

Quinn Karylle Fuentes · 32問 · 1年前

Unit 1

Unit 1

32問 • 1年前